OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001668243

UroGen Pharma Ltd. (URGN)

UroGen Pharma Ltd. (CIK 0001668243, ticker URGN) reported revenue of $109.79 million ($109,788,000) for FY2025 (2025-01-01 to 2025-12-31) and net income of -$153.49 million (-$153,494,000) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-03-02 (accession 0001437749-26-006234).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001668243
TickersURGN (Nasdaq)
EINnot in EDGAR (or not a valid EIN)
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationL3
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_44exqt5wp1k8pr311fd4mb8wr4
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$109,788,000FY20252025-01-01 to 2025-12-3110-K2026-03-020001437749-26-006234RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$153,494,000FY20252025-01-01 to 2025-12-3110-K2026-03-020001437749-26-006234NetIncomeLoss
Total assets$200,455,000FY2025as of 2025-12-3110-K2026-03-020001437749-26-006234Assets
Total liabilities$305,929,000FY2025as of 2025-12-3110-K2026-03-020001437749-26-006234Liabilities
Stockholders' equity-$105,474,000FY2025as of 2025-12-3110-K2026-03-020001437749-26-006234StockholdersEquity
Operating cash flow-$162,444,000FY20252025-01-01 to 2025-12-3110-K2026-03-020001437749-26-006234NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$4.96 per shareFY20212021-01-01 to 2021-12-3110-K2022-03-210001437749-22-006778EarningsPerShareBasicAndDiluted
Shares outstanding48,682,280 sharesFY2025as of 2026-02-2410-K2026-03-020001437749-26-006234EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$109,788,00010-K2026-03-020001437749-26-006234
RevenueFY20242024-01-01 to 2024-12-31$90,398,00010-K2026-03-020001437749-26-006234
RevenueFY20232023-01-01 to 2023-12-31$82,713,00010-K2025-03-100001437749-25-006842
RevenueFY20222022-01-01 to 2022-12-31$64,357,00010-K2024-03-140001437749-24-007753
RevenueFY20212021-01-01 to 2021-12-31$48,042,00010-K2023-03-240001437749-23-007710
RevenueFY20202020-01-01 to 2020-12-31$11,799,00010-K2022-03-210001437749-22-006778
RevenueFY20192019-01-01 to 2019-12-31$18,00010-K2021-03-180001564590-21-014016
RevenueFY20182018-01-01 to 2018-12-31$1,128,00010-K2019-02-280001564590-19-005323
Net incomeFY20252025-01-01 to 2025-12-31-$153,494,00010-K2026-03-020001437749-26-006234
Net incomeFY20242024-01-01 to 2024-12-31-$126,874,00010-K2026-03-020001437749-26-006234
Net incomeFY20232023-01-01 to 2023-12-31-$102,244,00010-K2025-03-100001437749-25-006842
Net incomeFY20222022-01-01 to 2022-12-31-$109,783,00010-K2024-03-140001437749-24-007753
Net incomeFY20212021-01-01 to 2021-12-31-$110,820,00010-K2023-03-240001437749-23-007710
Net incomeFY20202020-01-01 to 2020-12-31-$128,484,00010-K2022-03-210001437749-22-006778
Net incomeFY20192019-01-01 to 2019-12-31-$105,146,00010-K2021-03-180001564590-21-014016
Net incomeFY20182018-01-01 to 2018-12-31-$75,657,00010-K2020-03-020001564590-20-007970

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-052026-06-300001437749-26-025794urgn20260630_10q.htm
10-Q2026-05-062026-03-310001437749-26-015019urgn20260331_10q.htm
10-K2026-03-022025-12-310001437749-26-006234urgn20251231_10k.htm
10-Q2025-11-062025-09-300001437749-25-033468urgn20250930_10q.htm
10-Q2025-08-072025-06-300001437749-25-025243urgn20250630_10q.htm
10-Q2025-05-122025-03-310001437749-25-015956urgn20250331_10q.htm
10-K/A2025-04-302024-12-310001437749-25-013839urgn20241231_10ka.htm
10-K2025-03-102024-12-310001437749-25-006842urgn20241231_10k.htm
10-Q2024-11-062024-09-300001437749-24-033454urgn20240930c_10q.htm
10-Q2024-08-132024-06-300001437749-24-026161urgn20240630_10q.htm
10-Q2024-05-132024-03-310001437749-24-016116urgn20240331_10q.htm
10-K/A2024-04-292023-12-310001437749-24-013504urgn20231231_10ka.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001668243published by the sourcedata.sec.gov/submissions/CIK0001668243.json2026-10-21

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001668243.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001668243.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001668243" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001668243/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001668243/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1668243"}

On SEC EDGAR

About this data